Midgard

Ajinomoto Bio-Pharma Services

San Diego, CA, United States ajibio-pharma.ajinomoto.com From their website, Nov 2026

  • GLP
  • GMP

Work here? Claim this listing

About

Ajinomoto Bio-Pharma Services is a CDMO network serving biopharma companies developing and manufacturing small molecules, oligonucleotides, peptides, gene therapy products, proteins, and bioconjugates. It operates across Belgium, India, Japan, and the United States with specialized facilities and platform technologies supporting development through commercial supply.

Services

  • Small Molecule Manufacturing

    Develops and manufactures APIs and intermediates, including complex chemistry, hazardous chemistry, process intensification, micronization, and commercial supply.

  • Continuous Flow Chemistry

    Uses continuous flow processing to develop safer, more robust, and more sustainable routes for hazardous and complex chemistries from development through GMP commercial production.

  • High Potency API Manufacturing

    Manufactures HPAPIs with containment, toxicology, engineering, operational controls, and specialized training for compounds up to OEB5.

  • Research-Grade Oligonucleotide Manufacturing

    Produces research oligonucleotides from microgram and milligram scale through gram scale, including modified and complex sequences.

  • Clinical & Commercial Oligonucleotide Manufacturing

    Provides GMP oligonucleotide manufacturing from process development through clinical and commercial supply using solid-phase synthesis and AJIPHASE™ liquid-phase technology.

  • Custom Oligonucleotide Synthesis

    Supports custom DNA, RNA, long RNA, siRNA, LNA, and BNA™ synthesis for pharmaceutical, diagnostic, and research applications.

  • Enzymatic siRNA Synthesis

    Produces siRNA by enzyme-mediated ligation of multiple RNA fragments in a scalable fragment-based process.

  • Peptide Chemical Synthesis

    Manufactures peptide APIs by chemical synthesis using AJIPHASE™ for short, medium, long, cyclic, disulfide-constrained, PEGylated, and lipidated peptides.

9 more services
  • Peptide Biomanufacturing
  • Protein Manufacturing
  • VHH Antibody Manufacturing
  • ADC & Bioconjugation Services
  • Gene Therapy Manufacturing
  • Oligonucleotide Manufacturing
  • Peptide Manufacturing
  • Research-Grade Oligonucleotides
  • Site-Specific Conjugation Technology
What to send
For AJICAP™ early-stage evaluation, sample preparation can typically be completed within two weeks of receiving the nece

Capabilities

As they state on their website or in their listing.

Processes
  • Small molecule
  • Antibody
  • Bispecific
  • ADC
  • Peptide
  • Oligonucleotide
7 more
  • mRNA
  • Viral vector
  • Recombinant protein
  • LNP / formulation
  • Process development
  • AAV
  • LNP
Capacity
  • 1–8,000 L reactors
  • Up to 200 kg per batch
  • 500+ m³ total dedicated HPAPI capacity across network
  • OEB4 manufacturing capability
  • OEB5 manufacturing capability
  • OEB6 development capability
10 more
  • 15 kL fermentation scale
  • >100 kL fermentation capacities through partners
  • 2 GMP sites across Belgium and Japan
  • 100 GMP production campaigns
  • Solid-phase synthesis from μg to several kg
  • AJIPHASE™ up to 200 kg/batch
  • Gr grams to 200 kg/batch
  • Largest reactor used in GMP manufacturing: 8,000L
  • Enzymatic siRNA synthesis from several kilograms up to 200 kg
  • GenClip™ long RNA from 100 to 500 mer
Scales
Gram · Kilogram
Data supplied
LC-MS · HPLC

Equipment

  • PAT
  • LC-MS
  • HRMS
  • GC
  • HPLC
  • AEX-HPLC
4 more
  • SEC
  • IEX
  • RP-LC
  • UF/DF

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

  • GLPSelf-reported

Details

Type
CRDMO
Team
2,000+ employees worldwide
Based in
San Diego, CA, United States
Sites
  • Balen, Belgium
  • Wetteren, Belgium
  • Vizag, India
  • Kawasaki, Japan
  • Osaka, Japan
  • Tokyo, Japan
Serves
Worldwide

Public records

FDA drug establishment registration
1000542796 · LABEL source

Similar labs